학술논문
Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study
Document Type
Article
Author
Santoni, M.; Massari, F.; Mollica, V.; Takeshita, H.; Tapia, J.C.; Dionese, M.; Pichler, R.; Rizzo, M.; Lam, E.T.; Grande, E.; Kemp, R.; Molina-Cerrillo, J.; Calabrò, F.; Tural, D.; Küronya, Z.; Kucharz, J.; Fiala, O.; Seront, E.; Kopp, R.M.; Abahssain, H.; Kopecky, J.; Martignetti, A.; Kanesvaran, R.; Zakopoulou, R.; Ansari, J.; Landmesser, J.; Porta, C.; Bellmunt, J.; Salah, S.; Santini, D.
Source
In: Clinical and Experimental Medicine . (Clinical and Experimental Medicine, December 2023, 23(8):5413-5422)
Subject
Language
English
ISSN
15919528
15918890
15918890